Markeri zapaljenja kao prediktori smrtnog ishoda kod bolesnika sa dijagnozom delirijuma

  • Ivana Stašević Karličić Clinic for Psychiatric Disorders “Dr Laza Lazarević”, Belgrade, Serbia
  • Milena Stašević Clinic for Psychiatric Disorders “Dr Laza Lazarević”, Belgrade, Serbia
  • Slobodan Janković Clinic for Pharmacology, Toxicology and Clinical Pharmacology, Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
  • Slavica Djukić Dejanović Clinic for Pharmacology, Toxicology and Clinical Pharmacology, Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
  • Srdjan Milovanović Clinic for Psychiatry, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Ključne reči: delirium||, ||delirijum, intensive care units||, ||intenzivna nega, odeljenja, inflammation||, ||zapaljenje, biological markers||, ||biološki pokazatelji, c-reactive protein||, ||c-reaktivni protein, prognosis||, ||prognoza,

Sažetak


Uvod/Cilj. Delirijum je akutni ili subakutni, najčešće reverzibilni sindrom oštećenja viših kortikalnih funkcija, koji se ispoljava kao generalizovani poremećaj. Ako se ne spreči, povezan je sa mnogostrukim i brzim lošim ishodima. Cilj ovog istraživanja bio je da se ispita povezanost markera zapaljenja i smrtnog ishoda kod bolesnika sa dijagnozom delirijuma, hospitalizovanih u jedinici intenzivne psihijatrijske nege. Metode. Retrospektivnom studijom obuhvaćeno je 120 bolesnika lečenih u jedinici intenzivne psihijatrijske nege pod dijagnozom delirijuma kod kojih je sprovedeno istraživanje razlika markera inflamacije. Ispitanici su bili podeljeni u dve grupe: grupu koju je činilo 40 bolesnika umrlih za vreme bolničkog lečenja, i kontrolnu grupu od 80 preživelih ispitanika koji su otpušteni pod dijagnozom „stanje posle delirijuma“. Praćene su sledeće varijable: starost, pol, klinička dijagnoza infekcije (pneumonija i urinarna infekcija), laboratorijski parametri (ukupni leukociti, granulociti, monociti, C-reaktivni protein − CRP) i tip delirijuma (apstinencijalni ili organski). Rezultati. Prosečna starost ispitanika iznosila je 50,3 ± 13,1 godina. Bolesnici koji su preživeli delirijum bili su prosečno 10,5 godina mlađi od umrlih (p < 0,001). Više od polovine umrlih bolesnika (57,5%) imalo je pneumoniju. Utvrđena je statistički značajna povezanost pneumonije i smrtnog ishoda kod bolesnika sa delirijumom (p < 0,001). U grupi umrlih bolesnika, srednja vrednosti CRP-a bila je statistički značajno veća od vrednosti CRP u grupi preživelih (75,6 ± 54,0 vs 30,3 ± 42,5 ng/L, p < 0,001). Zaključak. U cilju bolje i preciznije dijagnostike ovog komplikovanog i još uvek nejasnog neuropsihijatrijskog sindroma, bilo bi korisno razmotriti uvođenje jasnog dijagnostičkog algoritma u svim jedinicama intenzivne nege. To bi moglo znatno smanjiti broj previda delirijuma, odnosno komplikovanje kliničke slike, stopu loših ishoda, a samim tim i ukupne troškove lečenja.

Reference

Gelder GM, Andreasen CN, Lopez-Ibor JJ, Geddes RJ. New Oxford Text book of Psychiatry. Oxford, UK: Oxford University Press; 2009.

Eeles EM, Hubbard RE, White SV, O'Mahony M, Savva GM, Bayer AJ. Hospital use, institutionalisation and mortality associated with delirium. Age Ageing 2010; 39(4): 470−5.

McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely WE, et al. Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 2011; 15(2): R78.

Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123(6): 2043−9.

Pepersack T, de Breucker S. Could geriatric comprehensive as-sessment predict the outcome of pneumonia in the very old. Age Ageing 2007; 36(4): 455−9.

Zhang Z, Pan L, Deng H, Ni H, Xu X. Prediction of delirium in critically ill patients with elevated C-reactive protein. J Crit Care 2014; 29(1): 88−92.

MacDonald A, Adamis D, Treloar A, Martin F. C-reactive protein levels predict the incidence of delirium and recovery from it. Age Ageing 2007; 36(2): 222−5.

Tsuruta R, Nakahara T, Miyauchi T, Kutsuna S, Ogino Y, Yamamoto T, et al.. Prevalence and associated factors for delirium in critically ill patients at a Japanese intensive care unit. Gen Hosp Psychiatry 2010; 32(6): 607−11.

Zhang Z, Pan L, Ni H. Impact of delirium on clinical outcome in critically ill patients: a meta-analysis. Gen Hosp Psychiatry 2013; 35(2): 105−11.

Salluh JI, Soares M, Teles JM, Ceraso D, Raimondi N, Nava VS, et al. Delirium epidemiology in critical care (DECCA): an inter-national study. Crit Care 2010; 14(6): R210.

Ely WE, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, et al. Delirium as a predictor of mortality in mechanically ven-tilated patients in the intensive care unit. JAMA 2004; 291(14): 1753−62.

Lin SM, Liu CY, Wang CH, Lin CH, Huang CD, Huang PY, et al. The impact of delirium on the survival of mechanically ven-tilated patients. Crit Care Med 2004; 32(11): 2254−9.

Lin SM, Huang CD, Liu CY, Lin HC, Wang CH, Huang PY, et al. Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J Crit Care 2008; 23(3): 372−9.

Ouimet S, Riker R, Bergeron N, Bergeon N, Cossette M, Kavanagh B, et al. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007; 33(6): 1007−13.

Shehabi Y, Riker RR, Bokesch PM, Wisemandle W, Shintani A, Ely WE. Delirium duration and mortality in lightly sedated, me-chanically ventilated intensive care patients. Crit Care Med 2010; 38(12): 2311−8.

Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely WE. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilatet patients. Crit Care 2005; 9(4): R375−81.

van den Boogaard M, Peters SA, van der Hoeven JG, Dagnelie PC, Leffers P, Pickkers P, et al. The impact of delirium on the pre-diction of in-hospital mortality in intensive care patients. Crit Care 2010; 14(4): R146.

van den Boogaard M, Schoonhoven L, van der Hoeven JG, van Achter-berg T, Pickkers P. Incidence and short-term consequences of delirium in critically ill patients: A prospective observational cohort study. Int J Nurs Stud 2012; 49(7): 775−83.

Mariz J, Santos NC, Afonso H, Rodrigues P, Faria A, Sousa N, et al. Risk and clinical-outcome indicators of delirium in an emergency department intermediate care unit (EDIMCU): an observational prospective study. BMC Emerg Med 2013; 13(1): 2.

Yamaguchi T, Tsukioka E, Kishi Y. Outcomes after delirium in a Japanese intensive care unit. Gen Hosp Psychiatry 2014; 36(6): 634−6.

Sharma A, Malhotra S, Grover S, Jindal SK. Incidence, prevalence, risk factor and outcome of delirium in intensive care unit: a study from India. Gen Hosp Psychiatry 2012; 34(6): 639−46.

Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing 2006; 35(4): 350−64.

Dusemund F, Chronis J, Baty F, Albrich CY, Brutsche MH. The outcome of community-acquired pneumonia in patients with chronic lung disease. Swiss Med Wkly 2014; 144: w14013.

Calle A, Márquez MA, Arellano M, Pérez LM, Pi-Figueras M, Mi-ralles R. Geriatric assessment and prognostic factors of mortality in very elderly patients with community-acquired pneumonia. Arch Bronconeumol 2014; 50(10): 429−34. (English, Spanish)

Marrie T. Community-Acquired Pneumonia in the Elderly. Clin Infect Dis 2000; 31(4): 1066−78.

Ewig S, Kleinfeld T, Bauer T, Seifert K, Schäfer H, Göke N. Com-parative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J 1999; 14(2): 370−5.

Riquelme R, Torres A, el-Ebiary M, Mensa J, Estruch R, Ruiz M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 1997; 156(6): 1908−14.

de Zuazu HM, López GT, Barandiaran FA, Irujo OV, López MA. Neumonía en el anciano. Factores relacionados con la mortali-dad durante el episodio y tras el alta hospitalaria. Med Clin 2004; 123(9): 332−6. (Italian)

Adamis D, Treloar A, Darwiche F, Gregson N, Macdonald AJ, Mar-tin FC. Associations of delirium with in-hospital and in 6-months mortality in elderly medical inpatients. Age Ageing 2007; 36(6): 644−9.

Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JU. Di-agnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30(3): 529−35.

Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2001; 19(1): 53−61.

Panichi V, Migliori M, de Pietro S, Taccola D, Bianchi AM, Norpoth M, et al. C-reactive protein as a marker of chronic inflamma-tion in uremic patients. Blood Purif 2000; 18(3): 183−90.

Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 383(9920): 911−22.

Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK. One-year health care costs associated with delirium in the el-derly population. Arch Intern Med 2008; 168(1): 27−32.

WHO Regional Office for Europe. European hospital morbidity database. Copenhagen: WHO Regional Office for Europe; 2012.

Organization for Economic Co-operation and Development. OECD health data 2012. Paris: Organization for Economic Co-operation and Development; 2012.

Objavljeno
2017/03/10
Broj časopisa
Rubrika
Originalni članak